Abstract
In 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began circulating worldwide and caused the coronavirus disease 2019 (COVID-19). To date, no highly effective treatments are available. Amantadine, an old, cheap and safe drug, is currently used for Parkinson’s disease and multiple sclerosis, as well as being known for its antiviral action. Recent reports suggested a possible efficacy of amantadine against SARS-CoV-2. The proposed treatment, upon demonstration of efficacy and safety, could be easily administered even in developing countries for its low cost (Eudract n.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
